India’s healthcare stakeholders — including hospitals, diagnostic chains, medical device firms, insurers and pharma groups — have responded positively to the rollout of GST 2.0, saying the tax changes announced under Prime Minister Narendra Modi’s leadership will alleviate cost pressures, expand access, and give a
In a significant policy development, the Government of Gujarat has reversed its earlier decision to exempt stents from the purview of central pricing regulation under the Clinical Establishments Act. This comes after broad-based feedback and concern from industry stakeholders, patient advocacy groups, and healthcare experts.Simultaneously,
